Extendicare Inc.
EXETF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.10 | -0.02 | -0.06 | -0.73 |
| FCF Yield | 10.89% | -17.18% | -0.50% | -0.93% |
| EV / EBITDA | 7.11 | 8.89 | 16.12 | 14.45 |
| Quality | ||||
| ROIC | 18.29% | 18.19% | 4.00% | 4.90% |
| Gross Margin | 100.00% | 12.85% | 6.29% | 9.91% |
| Cash Conversion Ratio | 1.91 | 0.69 | 1.42 | 5.51 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.27% | 3.80% | 1.79% | 1.02% |
| Free Cash Flow Growth | 195.82% | -3,540.79% | 52.21% | -106.92% |
| Safety | ||||
| Net Debt / EBITDA | 1.10 | 2.63 | 4.38 | 5.75 |
| Interest Coverage | 5.04 | 5.17 | 1.02 | 2.79 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 102.18 |
| Cash Conversion Cycle | 22.98 | -39.77 | -58.08 | -35.95 |